FMTX logo

FMTX Cash From Operations

Annual CFO

-$149.79 M
-$54.37 M-56.98%

December 31, 2021


Summary


Performance

FMTX Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherFMTXcash flowmetrics:

Quarterly CFO

-$44.76 M
+$4.53 M+9.19%

June 30, 2022


Summary


Performance

FMTX Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherFMTXcash flowmetrics:

TTM CFO

-$170.07 M
-$12.22 M-7.74%

June 30, 2022


Summary


Performance

FMTX TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherFMTXcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

FMTX Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-57.0%-37.6%-51.4%
3 y3 years-12.8%-38.6%-393.1%
5 y5 years-12.8%-225.3%-393.1%

FMTX Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low+8.6%+10.1%+13.5%at low
5 y5-year+334.3%at low+313.6%+10.1%+393.1%at low
alltimeall time+334.3%at low-225.3%+10.1%-576.1%at low

Forma Therapeutics Holdings Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2022
-
-$44.76 M(-9.2%)
-$170.07 M(+7.7%)
Mar 2022
-
-$49.30 M(+19.6%)
-$157.84 M(+5.4%)
Dec 2021
-$149.79 M(+57.0%)
-$41.20 M(+18.4%)
-$149.79 M(+23.9%)
Sep 2021
-
-$34.81 M(+7.0%)
-$120.90 M(+7.6%)
Jun 2021
-
-$32.54 M(-21.1%)
-$112.37 M(+8.8%)
Mar 2021
-
-$41.24 M(+234.7%)
-$103.24 M(+8.2%)
Dec 2020
-$95.42 M
-$12.32 M(-53.1%)
-$95.42 M(+1.6%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$26.27 M(+12.3%)
-$93.92 M(-0.9%)
Jun 2020
-
-$23.41 M(-30.0%)
-$94.74 M(-8.6%)
Mar 2020
-
-$33.42 M(+208.8%)
-$103.63 M(+200.5%)
Dec 2019
-$34.49 M(-74.0%)
-$10.82 M(-60.1%)
-$34.49 M(+45.7%)
Sep 2019
-
-$27.09 M(-16.1%)
-$23.67 M(-791.6%)
Jun 2019
-
-$32.30 M(-190.4%)
$3.42 M(-90.4%)
Mar 2019
-
$35.72 M
$35.72 M
Dec 2018
-$132.83 M
-
-

FAQ

  • What is Forma Therapeutics Holdings annual cash flow from operations?
  • What is the all time high annual CFO for Forma Therapeutics Holdings?
  • What is Forma Therapeutics Holdings annual CFO year-on-year change?
  • What is Forma Therapeutics Holdings quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Forma Therapeutics Holdings?
  • What is Forma Therapeutics Holdings quarterly CFO year-on-year change?
  • What is Forma Therapeutics Holdings TTM cash flow from operations?
  • What is the all time high TTM CFO for Forma Therapeutics Holdings?
  • What is Forma Therapeutics Holdings TTM CFO year-on-year change?

What is Forma Therapeutics Holdings annual cash flow from operations?

The current annual CFO of FMTX is -$149.79 M

What is the all time high annual CFO for Forma Therapeutics Holdings?

Forma Therapeutics Holdings all-time high annual cash flow from operations is -$34.49 M

What is Forma Therapeutics Holdings annual CFO year-on-year change?

Over the past year, FMTX annual cash flow from operations has changed by -$54.37 M (-56.98%)

What is Forma Therapeutics Holdings quarterly cash flow from operations?

The current quarterly CFO of FMTX is -$44.76 M

What is the all time high quarterly CFO for Forma Therapeutics Holdings?

Forma Therapeutics Holdings all-time high quarterly cash flow from operations is $35.72 M

What is Forma Therapeutics Holdings quarterly CFO year-on-year change?

Over the past year, FMTX quarterly cash flow from operations has changed by -$12.22 M (-37.57%)

What is Forma Therapeutics Holdings TTM cash flow from operations?

The current TTM CFO of FMTX is -$170.07 M

What is the all time high TTM CFO for Forma Therapeutics Holdings?

Forma Therapeutics Holdings all-time high TTM cash flow from operations is $35.72 M

What is Forma Therapeutics Holdings TTM CFO year-on-year change?

Over the past year, FMTX TTM cash flow from operations has changed by -$57.70 M (-51.35%)